This aspect of Nrf2’s function is particularly detrimental, as it not only facilitates tumor progression by protecting malignant cells from oxidative damage but also enables these cells to evade the cytotoxic effects of treatment, posing significant challenges for the management of HCC. This evidence concerns the gene NFE2L2 and neoplasm.